allr: the income statement

MyFinsight

Allarity Therapeutics, Inc. (ALLR)

For the quarter ending 2025-06-30, ALLR made $1,825K in revenue. -$2,320K in net income. Net profit margin of -127.12%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Deemed dividend on preferred stock-Series AConvertible Preferred Stock	-
Income tax benefit	-
Research and development	2,321
General and administrative	1,812
Total operating expenses	4,133
Loss from operations	-4,133
Interest income	237
Interest expense	12
Foreign exchange gains (losses)	1,588
Change in fair value of derivative and warrant liabilities	-
Total other income, net	1,813
Loss before income tax benefit	-2,320
Net loss	-2,320
Gain on extinguishment of series a convertible preferred stock-Series AConvertible Preferred Stock	-
Net loss attributable to common stockholders	-2,320

Net loss per common share, basic and diluted (in dollars per share)	-0.15
Weighted average common shares outstanding, basic and diluted (in shares)	15,543,321

Unit: Thousand (K) dollars (except for numbers of shares and EPS)